Novel Low Molecular Weight Spirodiketopiperazine Derivatives Potently Inhibit R5 HIV-1 Infection Through Their Antagonistic Effects on CCR5

Journal of Biological Chemistry - United States
doi 10.1074/jbc.m105670200
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Biochemistry & Molecular Biology (ASBMB)

Related search

Targeting CCR5 Trafficking to Inhibit HIV-1 Infection

Science advances
Multidisciplinary
2019English

Maraviroc for Previously Treated Patients With R5 HIV-1 Infection

Pediatrics
Child HealthPediatricsPerinatology
2009English

Fully Human Antagonistic Antibodies Against CCR4 Potently Inhibit Cell Signaling and Chemotaxis

PLoS ONE
Multidisciplinary
2014English

The IFITM Proteins Inhibit HIV-1 Infection

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2011English

482 GRL-142, a Novel HIV-1 Protease Inhibitor, Potently Blocks HIV-1 Ex Vivo Infection of Langerhans Cells Within Epithelium

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

High-Molecular-Weight Aliphatic Amines and Their Derivatives

English

Mechanism of Transdominant Inhibition of CCR5-mediated HIV-1 Infection by Ccr5Δ32

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1997English

Thymic Plasmacytoid Dendritic Cells Are Susceptible to Productive HIV-1 Infection and Efficiently Transfer R5 HIV-1 to Thymocytes in Vitro

Retrovirology
VirologyInfectious Diseases
2011English

Inefficient Entry of Vicriviroc-Resistant HIV-1 via the Inhibitor-Ccr5 Complex at Low Cell Surface CCR5 Densities

Virology
Virology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy